van Draanen J, Hamilton J, Morgan J, Maxwell S, Taylor T, Richardson L, Nolan S Supervised smoking facility access, harm reduction practices, and substance use changes during the COVID-19 pandemic: a community-engaged cross-sectional study Harm Reduct J, 2023. PubMed

Goodyear T, Oliffe JL, Parent N, Mniszak C, Jenkins E, Knight R Differentiating the role of alcohol in young men's use of substances with sex: a qualitative study Harm Reduct J, 2023. PubMed

Reddon H, Fairbairn N, Grant C, Milloy MJ Experiencing homelessness and progression through the HIV cascade of care among people who use drugs AIDS, 2023. PubMed

Ti L, Grant CJ, Tobias S, Hore DK, Laing R, Marshall BDL Development of a neural network model to predict the presence of fentanyl in community drug samples PLoS One, 2023. PubMed

Morgan J, Neufeld SD, Holroyd H, Ruiz J, Taylor T, Nolan S, Glegg S Community-Engaged Research Ethics Training (CERET): developing accessible and relevant research ethics training for community-based participatory research with people with lived and living experience using illicit drugs and harm reduction workers Harm Reduct J, 2023. PubMed

Mocanu V, Bozinoff N, Wood E, Jutras-Aswad D, Le Foll B, Lim R, Choi JC, Mok WY, Socías ME; OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse Opioid agonist therapy switching among individuals with prescription-type opioid use disorder: secondary analysis of a pragmatic randomized trial Drug Alcohol Depend, 2023. PubMed

Mayer S, Boyd J, Fairbairn N, Chapman J, Brohman I, Jenkins E, McNeil R Women's experiences in injectable opioid agonist treatment programs in Vancouver, Canada Int J Drug Policy, 2023. PubMed

Brooks O, Ng JCY, Ickowicz S Outpatient rapid titration of slow release oral morphine for the treatment of opioid use disorder in a Canadian setting: a case series J Addict Med, 2023. PubMed

El-Akkad S, Nolan S, Hayashi K, Dong H, Milloy MJ, DeBeck K, Ti L Factors associated with patient perceived suboptimal dosing of in-hospital opioid agonist therapy among people who use illicit drugs in Vancouver, Canada J Addict Dis, 2023. PubMed

Javanbakht M, Khan L, Mustanski B, Shoptaw S, Baum MK, Mehta SH, Kirk GD, Lai S, Moore R, Milloy MJ, Kipke M, Hayashi K, DeBeck K, Siminski S, White LM, Gorbach P Substance use and other factors associated with COVID-19 vaccine uptake among people at risk for or living with HIV: findings from the C3PNO Consortium Prev Med Rep, 2023. Link